- Filed
- May 8, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · May 6, 2020 | 193.08M sh |
| Stock Issued | Q1 2020 · Mar 31, 2020 | 0 sh |
| Stock Issued | Q1 2020 · Mar 31, 2019 | 2M sh |
| Shares Diluted | Q1 2020 · Mar 31, 2020 | 193M sh |
| Shares Diluted | Q1 2020 · Mar 31, 2019 | 181M sh |
| Capex | Q1 2020 · Mar 31, 2020 | $25M |
| Capex | Q1 2020 · Mar 31, 2019 | $18M |
| Operating Cash Flow | Q1 2020 · Mar 31, 2020 | −$695M |
| Operating Cash Flow | Q1 2020 · Mar 31, 2019 | −$244M |
| Cash And Equivalents | Q1 2020 · Mar 31, 2020 | $1.18B |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $790M |
| Stockholders Equity | Q1 2020 · Mar 31, 2020 | −$3.6B |
| Stockholders Equity | Q1 2020 · Dec 31, 2019 | −$2.14B |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $5.89B |
| Current Liabilities | Q1 2020 · Dec 31, 2019 | $9.44B |
| Current Assets | Q1 2020 · Mar 31, 2020 | $6.24B |
| Current Assets | Q1 2020 · Dec 31, 2019 | $3.56B |
| Total Assets | Q1 2020 · Mar 31, 2020 | $8.3B |
| Total Assets | Q1 2020 · Dec 31, 2019 | $8.74B |
| Sga Expense | Q1 2020 · Mar 31, 2020 | $62M |
| Sga Expense restated | Q1 2020 · Mar 31, 2019 | $68M |
| Rd Expense | Q1 2020 · Mar 31, 2020 | $2M |
| Rd Expense restated | Q1 2020 · Mar 31, 2019 | $2M |
| Net Income | Q1 2020 · Mar 31, 2020 | −$1.38B |
| Net Income | Q1 2020 · Mar 31, 2019 | −$56M |
| Operating Income | Q1 2020 · Mar 31, 2020 | −$1.05B |
| Operating Income restated | Q1 2020 · Mar 31, 2019 | −$25M |
| Cost Of Revenue | Q1 2020 · Mar 31, 2020 | $1.86B |
| Cost Of Revenue restated | Q1 2020 · Mar 31, 2019 | $1.93B |
| Revenue | Q1 2020 · Mar 31, 2020 | $1.91B |
| Revenue restated | Q1 2020 · Mar 31, 2019 | $2.06B |
| Stock Repurchased | Q1 2020 · Mar 31, 2019 | $4M |